![]() |
市场调查报告书
商品编码
1858593
全球二甲基亚砜市场趋势、应用与预测分析Dimethyl Sulfoxide Market, Trends, Applications and Forecast Analysis |
||||||
二甲基亚砜的需求量
从应用领域来看,製药业是二甲基亚砜(DMSO)的最大消费产业,其用途广泛,涵盖药物载体和冷冻保护剂等。 DMSO 具有抗发炎、镇痛、抗菌、抗真菌和抗病毒特性,使其作为药物中间体广泛应用。 DMSO 能够以最小的组织损伤穿透人体皮肤,因此被应用于经皮给药系统,为止痛药和类固醇等药物的给药提供了一种有效途径。 DMSO 也获准用于治疗膀胱疼痛症候群,并用于干细胞和骨髓保存。
在农业化学品领域,二甲基亚砜(DMSO)用作除草剂和杀虫剂合成的反应介质,有助于提高吸收率和製剂稳定性。 DMSO 也可用于加速土壤反应并提高农药的药效。此外,DMSO 也应用于聚合物加工、清洁剂和脱漆剂等领域,其优异的溶解性能使其能够溶解多种树脂、涂料和有机基材。
二甲基亚砜区域需求分析
亚太地区引领全球二甲基亚砜(DMSO)市场,这主要得益于中国、印度和韩国等国强大的製药生产基础设施以及活性化的农业活动。区域政府对医疗保健扩张的支持、活性药物成分(API)的在地化生产以及对作物保护解决方案不断增长的投资,都在推动市场需求。北美地区凭藉其发达的製药行业以及对经皮吸收贴片先进给药系统的日益依赖,仍然是领先的市场。在美国,监管核准和临床研究的进展正在推动DMSO在製剂和临床实验药物中的应用。
在西欧,严格的环境法规推动工业和製药领域使用环保和可生物降解溶剂,刺激了市场需求。在拉丁美洲和中东及非洲等新兴经济体,不断扩大的农业化学品市场和不断完善的医疗基础设施正逐步提升二甲基亚砜(DMSO)的消费量,为预测期内的良好增长奠定了基础。
主要製造商
主要生产商包括盖洛德化学公司、阿科玛公司、湖北兴发化学集团有限公司和东丽精细化学公司。
市场驱动因素:製药业的成长
DMSO市场的主要成长动力在于其在製药业日益广泛的应用。全球对健康和治疗方法创新的关注度不断提高,尤其是在新冠疫情之后。随着对更有效、更微创的药物递送系统的需求不断增长,DMSO作为一种可渗透皮肤的溶剂的作用也愈发重要。此外,干细胞和再生医学的復兴也推动了其作为冷冻保护剂的应用。
在农业化学品领域,提高农业生产力和减少化学品径流的压力日益增大,促使人们采用高效载体,例如二甲基亚砜(DMSO),它可以提高农药的溶解度和药效。 DMSO 能够提高反应速率并促进其有效渗入土壤,使其成为永续农业中备受重视的投入物。在工业应用领域,对环保溶剂的需求不断增长,尤其是在涂料和清洁剂领域,这推动了市场对 DMSO 的需求。
市场限制因素:监理制约因素
二甲基亚砜( DMSO)市场面临一些限制因素。围绕DMSO医疗用途的监管不确定性限制了其在一些国家的广泛应用。儘管美国FDA已核准其用于有限的医疗用途,但由于对其潜在副作用的核准以及缺乏针对特定用途的广泛临床试验,DMSO在世界许多地区仍未获准用于医疗用途或受到限制。
本报告分析了全球二甲基亚砜市场,并提供了市场动态和行业趋势、各细分市场的需求预测以及製造商概况等资讯。
Dimethyl Sulfoxide
Dimethyl sulfoxide (DMSO) is a colorless, organosulfur compound extensively utilized across various industries, particularly pharmaceuticals and agrochemicals. Derived primarily as a by-product of the Kraft pulping process through oxidation of dimethyl sulfide, DMSO has gained prominence as a biodegradable, non-toxic solvent that replaces more hazardous chemical counterparts. Its high polarity, aprotic characteristics, and ability to dissolve both polar and non-polar compounds make it indispensable in numerous formulations. DMSO has evolved from a specialty solvent to a vital pharmaceutical intermediate with increasing relevance in modern medicine and crop protection systems due to its therapeutic properties and ability to enhance cellular membrane penetration.
Dimethyl Sulfoxide Demand, by Application
Based on application segments, the pharmaceutical industry represents the largest consumer base for DMSO, driven by its multifaceted roles ranging from a drug carrier to a cryoprotectant. DMSO's anti-inflammatory, analgesic, antibacterial, antifungal, and antiviral properties underpin its widespread application as a pharmaceutical intermediate. The compound is employed in transdermal drug delivery systems due to its ability to penetrate human skin with minimal tissue disruption, offering an effective route for administering medications such as pain relief formulations and steroids. DMSO is also approved for treating bladder pain syndrome and is used in preserving stem cells and bone marrow.
In agrochemicals, DMSO serves as a reaction medium for synthesizing herbicides and insecticides, aiding in enhanced absorption and improved formulation stability. It is employed to accelerate soil reaction kinetics and improve agrochemical efficacy. Other applications include its use in cleaning solutions, paint stripping, and polymer processing leveraging DMSO's excellent solvency power to dissolve a broad range of resins, coatings, and organic substrates.
Dimethyl Sulfoxide Regional Demand Analysis
Asia Pacific leads the global DMSO market, attributed to robust pharmaceutical manufacturing infrastructure and increasing agricultural activities in countries such as China, India, and South Korea. The demand is reinforced by regional government support for healthcare expansion, local production of active pharmaceutical ingredients (APIs), and growing investments in crop protection solutions. North America follows as a key market, with a well-established pharmaceutical sector and an increasing reliance on advanced drug delivery systems, such as transdermal patches. Regulatory approval and clinical research initiatives in the U.S. drive the uptake of DMSO in drug formulations and investigational therapies.
In Western Europe, the demand is propelled by strict environmental regulations promoting the use of eco-friendly and biodegradable solvents in industrial and pharmaceutical applications. Emerging economies in Latin America and the Middle East & Africa are witnessing a gradual rise in DMSO consumption due to expanding agrochemical markets and improving healthcare infrastructure, offering promising growth avenues during the forecast period.
Key Manufacturers
Prominent players include Gaylord Chemical Corporation, Arkema, Hubei Xingfa Chemicals Group Co., Ltd., Toray Fine Chemicals.
Market Driver: Growing pharmaceutical industry
The primary growth driver for the DMSO market is its expanding application in the pharmaceutical industry, especially after the COVID-19 pandemic, which heightened global awareness regarding health and therapeutic innovations. As demand for more effective, less invasive drug delivery systems increases, DMSO's role as a skin-penetrating solvent becomes more vital. The resurgence in stem cell and regenerative medicine has also bolstered its application as a cryoprotective agent.
In agrochemicals, growing pressure to increase agricultural productivity and reduce chemical runoff is encouraging the adoption of highly efficient carriers like DMSO, which enhance agrochemical solubility and performance. The compound's ability to improve reaction rates and facilitate effective soil integration makes it a valued input in sustainable agriculture. The shift toward environmentally benign solvents in industrial applications supports its demand, especially in coatings and cleaning agents.
Market Restraint: Regulatory restrictions
Dimethyl sulfoxide market faces certain constraints. Regulatory uncertainty in some countries surrounding the medical application of DMSO restricts its full-scale adoption. While the U.S. FDA has approved limited pharmaceutical use, DMSO remains unapproved or controlled for medicinal purposes in many global regions due to concerns over its potential side effects and lack of large-scale clinical trials in certain use cases.
Note: Demand Analysis has been provided for all major Regions / Countries as mentioned below. The demand (consumption) split by applications have been provided for each of the countries / regions in Volume (Kilo tons) and Value (USD Million).
Note: CAGR will be calculated for all applications to arrive at the regional / global demand growth for the forecast period (2025 - 2034)
Note: This section includes company information, company financials, manufacturing bases and operating regions. Company financials have been mentioned only for those companies where financials were available in SEC Filings, annual reports, or company websites. All the reported financials in this report are in U.S. Dollars. Financials reported in other currencies have been converted using average currency conversion rates. Company profiles may include manufacturers, suppliers, and distributors.